Here's what we'll cover
Here's what we'll cover
If you are on Medicare and have been watching the GLP-1 coverage conversation unfold, you are not alone. Millions of older adults are asking the same question: does Medicare finally cover these medications for weight loss, and do I qualify?
The answer is more nuanced than a simple yes or no. Here is what weight management specialists and policy experts want you to understand before you call your doctor or switch your Medicare plan.
Why Medicare Coverage for GLP-1s Is a Big Deal
For years, Medicare was legally prohibited from covering medications used primarily for weight loss. That changed with new federal policy guidance that allows Medicare Part D plans to cover GLP-1 receptor agonists when they are prescribed for obesity, not just for type 2 diabetes or cardiovascular disease.
This matters because GLP-1 medications like semaglutide and tirzepatide are among the most expensive drug classes on the market. Without insurance, monthly costs can run from $900 to over $1,300. For Medicare beneficiaries living on fixed incomes, that price point made access essentially impossible.
The policy shift means that, for the first time, obesity can be treated as a primary diagnosis under Medicare drug coverage, rather than a risk factor that only gets addressed when another disease develops.
Who Actually Qualifies Under Medicare's GLP-1 Rules
Qualifying for Medicare coverage of a GLP-1 medication is not automatic just because you have a Medicare Part D plan. There are specific clinical criteria that must be met, and your prescribing physician will need to document them carefully.
BMI Requirements
The standard threshold mirrors what private insurers typically require. You generally need:
- A BMI of 30 or higher, which is classified as obesity under standard clinical criteria
- A BMI of 27 or higher combined with at least one weight-related health condition such as type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease
Weight-related conditions that may qualify include type 2 diabetes, high blood pressure, high cholesterol, obstructive sleep apnea, or cardiovascular disease.
Prior Authorization Is Common
Most Part D plans will require prior authorization before approving a GLP-1 for weight management. This means your doctor submits documentation to the insurer showing that you meet the clinical criteria and that the medication is medically necessary. Expect this process to take anywhere from a few days to a few weeks.
Your physician's role here is critical. Detailed, thorough documentation significantly improves the chance of approval on the first submission.
Which GLP-1 Medications Are Covered (And Which Are Not)
Not every GLP-1 drug on the market is covered for weight management under Medicare, and this is where patients often get confused.
The key distinction is FDA indication. Wegovy and Zepbound carry FDA approval specifically for chronic weight management, which makes them the primary candidates for obesity-related Medicare coverage. Ozempic and Mounjaro are approved for type 2 diabetes, so they are typically only covered under Medicare when prescribed for that condition.
What Coverage Actually Costs Under Part D
Coverage does not mean free. Medicare Part D operates with deductibles, copays, and coinsurance, and the amount you pay depends heavily on your specific plan.
Under the Inflation Reduction Act changes that took effect in 2025, out-of-pocket drug costs under Medicare Part D are now capped at $2,000 per year. That is meaningful protection for anyone who needs an expensive medication long-term.
However, before you hit that cap, you will likely pay:
- A monthly premium for your Part D plan, which varies by the specific plan you are enrolled in
- An annual deductible, which varies by plan but can be up to $590 in 2025, paid before coverage activates
- Copays or coinsurance at each fill, which vary by plan tier and may run 25 to 33 percent of the drug's cost until you reach catastrophic coverage
GLP-1 medications for weight loss are often placed on higher formulary tiers, meaning your cost-sharing percentage may be 25% to 33% of the drug's cost until you reach catastrophic coverage.
Comparing Plans During Open Enrollment
If GLP-1 access is a priority for you, the best time to act is during Medicare Open Enrollment (October 15 to December 7 each year). Use Medicare's Plan Finder tool at Medicare.gov to filter plans by whether they cover your specific medication.
Not all Part D plans will add GLP-1 weight management coverage, so plan selection is genuinely important and worth spending time on.
The Role of Behavioral Counseling in Coverage Approval
Here is something many patients do not expect. Weight management experts consistently emphasize that Medicare's approach to obesity treatment is not just about writing a prescription. Coverage guidelines often require that medication is used as part of a comprehensive program.
This typically means your treatment plan should include behavioral counseling or a structured lifestyle intervention. Medicare already covers intensive behavioral therapy for obesity under Part B, which includes up to 22 covered visits in the first year with a primary care provider.
Combining behavioral counseling with GLP-1 medication is not just a coverage requirement for some plans. It is also the clinical standard that produces the best long-term outcomes, according to major obesity medicine guidelines.
If your doctor is only offering the medication without discussing lifestyle support, that is worth a conversation. Ask specifically whether a referral to a registered dietitian or structured behavioral program is appropriate for your situation.
What to Do If Your Coverage Is Denied
Denials happen, even when you clearly meet the clinical criteria. Do not accept a denial as the final word. You have the right to appeal, and success rates for well-documented appeals are meaningful.
Steps to Take After a Denial
- Request the denial letter in writing and read the specific reason.
- Ask your doctor to review the denial and add or clarify clinical documentation.
- File a formal appeal with your Part D plan. You typically have 60 days from the denial notice.
- If the first appeal fails, you can escalate to an independent review entity.
In parallel, ask your prescribing physician about manufacturer patient assistance programs. Both Novo Nordisk (maker of Wegovy) and Eli Lilly (maker of Zepbound) offer savings programs that may apply even for Medicare patients in certain situations. You can also explore GLP-1 Coupons and savings resources that may help bridge costs during the appeals process.
Questions to Ask Your Doctor Before Starting
Walking into your appointment prepared makes a real difference in the outcome. Weight management specialists recommend asking these specific questions:
- Do I meet the clinical criteria for Medicare to cover a GLP-1 medication for obesity, and is my documentation in order to support a prior authorization?
- Which specific drug will you prescribe, and is it covered under my current Part D plan's formulary?
- Will you submit a prior authorization, and what clinical documentation will you include to strengthen the submission?
- Is there a behavioral counseling program I should participate in alongside this medication, given that some plans require it and it improves long-term outcomes?
- What results should I expect in the first three to six months, and how will we measure my progress?
- What happens if I reach my coverage limit or if my plan's formulary changes at the next open enrollment?
These questions set a clear expectation for both you and your provider and can prevent surprises down the road.
How to Find Providers Who Understand Medicare and GLP-1s
Not every primary care doctor is up to date on the nuances of Medicare's GLP-1 coverage rules. Obesity medicine specialists and endocrinologists tend to have more experience navigating prior authorizations for these medications.
If your current doctor seems unfamiliar with the process or unwilling to help, seeking a second opinion from a provider who focuses on weight management is a reasonable step. Telehealth providers have also become a practical option for many patients, offering access to physicians who regularly prescribe GLP-1 medications and understand insurance workflows.
You can compare providers who specialize in GLP-1 prescribing and understand how to work within Medicare's requirements by visiting Best Providers.
No waiting list. No insurance needed.
Frequently Asked Questions
Does Medicare cover Wegovy for weight loss?
Some Medicare Part D plans now cover Wegovy (semaglutide 2.4 mg) for chronic weight management following federal policy changes that allow obesity to be treated as a primary diagnosis. Coverage is plan-dependent, and prior authorization is typically required. Check your specific plan's formulary and use Medicare's Plan Finder to compare options during Open Enrollment.
What is the Medicare out-of-pocket cap for GLP-1 medications in 2025?
Under the Inflation Reduction Act, Medicare Part D out-of-pocket drug costs are capped at $2,000 per year starting in 2025. This cap applies to all covered drugs including GLP-1 medications, providing significant protection for patients who need expensive medications monthly.
Does Medicare cover Ozempic for weight loss?
Ozempic (semaglutide) is FDA-approved for type 2 diabetes, not weight management. Medicare will typically only cover Ozempic when it is prescribed for diabetes. If you need a semaglutide-based medication covered for obesity, Wegovy is the version with FDA approval for weight management and is more likely to qualify under Medicare's expanded coverage rules.
What BMI do you need for Medicare to cover GLP-1 medications?
Medicare guidelines generally require a BMI of 30 or higher for obesity coverage, or a BMI of 27 or higher if you also have at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea. Your doctor must document these criteria when submitting a prior authorization request.
How do I appeal a Medicare denial for a GLP-1 medication?
Request the denial in writing and identify the specific reason. Ask your doctor to strengthen or clarify the clinical documentation and then file a formal appeal with your Part D plan within 60 days of the denial notice. If the first appeal is denied, you can escalate to an independent review entity for further review.
Is Zepbound covered by Medicare for weight loss?
Zepbound (tirzepatide) carries FDA approval for chronic weight management, making it a candidate for Medicare Part D coverage under the new obesity coverage rules. As with Wegovy, coverage is plan-dependent and requires prior authorization. Not all Part D plans will include it on their formulary, so checking your specific plan's drug list is essential.
The Bottom Line on Medicare and GLP-1 Access
The expansion of Medicare coverage for GLP-1 medications is genuinely significant for the roughly 67 million Americans enrolled in Medicare, many of whom have been managing obesity without access to the most effective modern treatments available.
But access is not automatic or simple. The path from "Medicare now covers GLP-1s for weight loss" to actually having a covered prescription in hand requires understanding which drugs qualify, which plans include them, whether you meet clinical criteria, and how to navigate prior authorization and potential denials.
Weight management experts are consistent in their guidance. Get informed before your appointment. Know your BMI, know your health conditions, and know which medication your doctor plans to prescribe. That preparation directly affects your likelihood of approval and can shorten the time it takes to get started.
What This Means If You Are Already on a GLP-1
If you are currently taking a GLP-1 medication and paying out of pocket or through private insurance, the Medicare coverage expansion is worth revisiting, especially if your coverage situation has changed or if you will be aging into Medicare soon. Switching to a Medicare plan that covers your medication could meaningfully reduce your annual costs.
If you are approaching Medicare eligibility, this is the right time to prioritize finding a Part D plan that includes your specific medication on its formulary. A plan that saves you $800 or more per month is worth the research investment during Open Enrollment.
What This Means If You Are Just Starting Your GLP-1 Journey
If you are a Medicare beneficiary who has not yet started a GLP-1 medication but is considering it, you are entering the conversation at a better moment than most people who came before you. Coverage options exist now that simply did not a few years ago.
Start with a conversation with your primary care provider or a weight management specialist. If cost has been the barrier, ask specifically about Medicare coverage eligibility for your situation. Do not assume it is unavailable without checking.
You can also use the resources on GLP-1.com to compare providers who work with Medicare patients, explore potential savings through our GLP-1 Coupons page, and review detailed information on medications like Wegovy and Mounjaro to understand your options. When you are ready to find a prescribing provider, our Best Providers comparison can help you identify someone experienced in GLP-1 prescribing and Medicare coverage navigation.
Access to effective obesity treatment has been out of reach for too long for too many people. That is slowly changing, and being informed is the first and most practical step you can take right now.